[
  {
    "ts": null,
    "headline": "Kenvue Stock Tumbles on Report Kennedy Will Link Autism and Tylenol",
    "summary": "Acetaminophen, the active ingredient in Tylenol, is one of the few pain relief and fever reduction medicines recommended for pregnant women.",
    "url": "https://finnhub.io/api/news?id=0806029b863c146994d7c29ea087c0a4a4b089c33eaba736335572b541eafe26",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757100540,
      "headline": "Kenvue Stock Tumbles on Report Kennedy Will Link Autism and Tylenol",
      "id": 136651489,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Acetaminophen, the active ingredient in Tylenol, is one of the few pain relief and fever reduction medicines recommended for pregnant women.",
      "url": "https://finnhub.io/api/news?id=0806029b863c146994d7c29ea087c0a4a4b089c33eaba736335572b541eafe26"
    }
  },
  {
    "ts": null,
    "headline": "Ronovo Surgical Closes Series D Financing",
    "summary": "SHANGHAI, September 05, 2025--Ronovo Surgical, a global innovator in next-generation surgical robotics, announced today the successful closing of its Series D financing, led by Johnson & Johnson’s corporate venture capital organization, JJDC, and participation from Lilly Asia Ventures, INCE Capital and Granite Asia, with a total investment of USD 67 million.",
    "url": "https://finnhub.io/api/news?id=b483c5815de4972f0f6dc99ebff01560b68db8b3dc3f1c4d42e15d09603004bd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757099700,
      "headline": "Ronovo Surgical Closes Series D Financing",
      "id": 136652838,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "SHANGHAI, September 05, 2025--Ronovo Surgical, a global innovator in next-generation surgical robotics, announced today the successful closing of its Series D financing, led by Johnson & Johnson’s corporate venture capital organization, JJDC, and participation from Lilly Asia Ventures, INCE Capital and Granite Asia, with a total investment of USD 67 million.",
      "url": "https://finnhub.io/api/news?id=b483c5815de4972f0f6dc99ebff01560b68db8b3dc3f1c4d42e15d09603004bd"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of September 7",
    "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the full article here.",
    "url": "https://finnhub.io/api/news?id=ff914b676260c3d875ed7f5add1e0b873c78fd74eee4f340db91c840588fe9c1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757099009,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of September 7",
      "id": 136651455,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the full article here.",
      "url": "https://finnhub.io/api/news?id=ff914b676260c3d875ed7f5add1e0b873c78fd74eee4f340db91c840588fe9c1"
    }
  },
  {
    "ts": null,
    "headline": "BDTX Stock Surges 51.1% in Six Months: Is There More Room for Growth?",
    "summary": "Black Diamond shines with a 51.1% stock surge, fueled by silevertinib's progress and pipeline momentum in oncology.",
    "url": "https://finnhub.io/api/news?id=6f839e41453b41784acebc08e7614f3392e0c09a9d66599d026d26f553f54b98",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757087580,
      "headline": "BDTX Stock Surges 51.1% in Six Months: Is There More Room for Growth?",
      "id": 136652839,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Black Diamond shines with a 51.1% stock surge, fueled by silevertinib's progress and pipeline momentum in oncology.",
      "url": "https://finnhub.io/api/news?id=6f839e41453b41784acebc08e7614f3392e0c09a9d66599d026d26f553f54b98"
    }
  },
  {
    "ts": null,
    "headline": "Tylenol maker Kenvue's stock heads for a record selloff after troubling WSJ report",
    "summary": "Tylenol maker Kenvue's stock heads for a record selloff after troubling WSJ report",
    "url": "https://finnhub.io/api/news?id=1c594a97a19ec7a3f22a241875bcf744db4d1ff4bbc463dbae4085088f7e61fb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757085377,
      "headline": "Tylenol maker Kenvue's stock heads for a record selloff after troubling WSJ report",
      "id": 136721783,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Tylenol maker Kenvue's stock heads for a record selloff after troubling WSJ report",
      "url": "https://finnhub.io/api/news?id=1c594a97a19ec7a3f22a241875bcf744db4d1ff4bbc463dbae4085088f7e61fb"
    }
  },
  {
    "ts": null,
    "headline": "Acetaminophen Market Trends and Forecasts, 2023-2024 & 2025-2033 | Rising OTC Demand, Wider Access to Essential Medicines, and Growth in Combination Therapies Drive Expansion",
    "summary": "The global acetaminophen market is set to grow at a CAGR of 4.5% from 2025-2033, driven by continued demand for OTC pain relief and expanding access to essential medicines. Widely used across age groups for pain and fever, its usage in combination therapies and among vulnerable populations boosts growth.Dublin, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The \"Acetaminophen Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts,",
    "url": "https://finnhub.io/api/news?id=c08c7c1463a13dc61f208c3e9f91763e56d9ad7a2af3cce4cece0dae2f7b77c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757069580,
      "headline": "Acetaminophen Market Trends and Forecasts, 2023-2024 & 2025-2033 | Rising OTC Demand, Wider Access to Essential Medicines, and Growth in Combination Therapies Drive Expansion",
      "id": 136647791,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The global acetaminophen market is set to grow at a CAGR of 4.5% from 2025-2033, driven by continued demand for OTC pain relief and expanding access to essential medicines. Widely used across age groups for pain and fever, its usage in combination therapies and among vulnerable populations boosts growth.Dublin, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The \"Acetaminophen Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts,",
      "url": "https://finnhub.io/api/news?id=c08c7c1463a13dc61f208c3e9f91763e56d9ad7a2af3cce4cece0dae2f7b77c3"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: Still A Bargain Despite Kennedy's Anti-Vaccine Attacks",
    "summary": "Pfizer Inc.'s strong Q2 2025 sales defy expectations. Discover analyst insights, growth drivers, and why it's rated Strong Buy. Click for my PFE stock update.",
    "url": "https://finnhub.io/api/news?id=d73fe54fc34318ccf1d3729ec1a04d051d9f77957ff3802476624a400c8c850d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757063226,
      "headline": "Pfizer: Still A Bargain Despite Kennedy's Anti-Vaccine Attacks",
      "id": 136647643,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1304540314/image_1304540314.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Pfizer Inc.'s strong Q2 2025 sales defy expectations. Discover analyst insights, growth drivers, and why it's rated Strong Buy. Click for my PFE stock update.",
      "url": "https://finnhub.io/api/news?id=d73fe54fc34318ccf1d3729ec1a04d051d9f77957ff3802476624a400c8c850d"
    }
  }
]